Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022

SELL
$3.34 - $9.2 $178,222 - $490,911
-53,360 Reduced 66.31%
27,111 $91,000
Q2 2022

Aug 01, 2022

SELL
$6.39 - $16.24 $38 - $97
-6 Reduced 0.01%
80,471 $676,000
Q1 2022

May 04, 2022

SELL
$12.79 - $21.64 $29,378 - $49,707
-2,297 Reduced 2.78%
80,477 $1.04 Million
Q4 2021

Feb 07, 2022

SELL
$17.49 - $26.72 $151,743 - $231,822
-8,676 Reduced 9.49%
82,774 $1.7 Million
Q3 2021

Nov 02, 2021

BUY
$17.47 - $27.49 $18,360 - $28,891
1,051 Added 1.16%
91,450 $2.28 Million
Q2 2021

Aug 03, 2021

BUY
$23.73 - $27.98 $2.15 Million - $2.53 Million
90,399 New
90,399 $2.15 Million

Others Institutions Holding TKNO

About Alpha Teknova, Inc.


  • Ticker TKNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 28,080,500
  • Market Cap $206M
  • Description
  • Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; ...
More about TKNO
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.